Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cytophage Technologies Ltd V.CYTO

Alternate Symbol(s):  CPTCF

Cytophage Technologies Ltd. is a Canadian biotechnology company. The Company uses advanced molecular genetic techniques and synthetic biology to create bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals... see more

Recent & Breaking News (TSXV:CYTO)

    Cytophage Announces Fiscal Year End 2023 Results

    TheNewsWire April 30, 2024

    Cytophage Appoints New Board Director

    TheNewsWire April 16, 2024

    Cytophage Provides Update on Bacteriophage Human Trial at The Ottawa Hospital

    TheNewsWire April 2, 2024

    Cytophage Provides Bacteriophages for Landmark Treatment of Joint Replacement Infection in Canada

    TheNewsWire March 1, 2024

    Cytophage Update on Upcoming Product for Egg Production in Canada

    TheNewsWire February 12, 2024

    Cytophage Technologies Ltd. Completes Reverse Takeover Transaction of Cuspis Capital III Ltd.

    TheNewsWire February 2, 2024

    Cuspis Capital III Ltd. Announces Filing of Filing Statement with Respect to its Qualifying Transaction

    TheNewsWire February 2, 2024

    Cuspis Capital III Ltd. Announces Closing of Concurrent Financing by Cytophage Technologies Inc., Receipt of TSXV Conditional Approval, and Certain Loans

    TheNewsWire December 22, 2023

    Cuspis Capital III Ltd. and Cytophage Technologies Inc. Announce Execution of Business Combination Agreement and Concurrent Financing

    TheNewsWire November 6, 2023

    Cuspis Capital III Ltd. and Cytophage Technologies Inc. Enter into Letter of Intent for Qualifying Transaction

    TheNewsWire June 1, 2023

    Canadian Investment Regulatory Organization Trading Halt - CIII.P

    Canada NewsWire June 1, 2023